RxDoctor Payments Data

Noralie Raudszus

Nurse Practitioner · Glendale, CANPI 1548765225

Payments from drug & device makers

$4,364in general payments, 2019–2025

Across 215 payments — averaging $20.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fresenius USA Marketing, Inc.$1K
  • Akebia Therapeutics Inc$938
  • AstraZeneca$706
  • Bayer$349
  • Ardelyx, Inc.$228
  • Aurinia Pharma U.S., Inc.$199
  • plus $802 from 11 others

What the payments were for

  • Food & beverage$4,30599%
  • Education$581%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,364 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide52$152,161
Sevelamer Carbonate166$97,969
Sevelamer Hcl54$74,613
XphozahTenapanor Hcl22$71,270
ProsolParenteral Amino Acid 20% No.1376$55,609
VeltassaPatiromer Calcium Sorbitex29$33,903
RenvelaSevelamer Carbonate12$20,862
LokelmaSodium Zirconium Cyclosilicate26$20,381
AuryxiaFerric Citrate13$16,506
ClinisolParenteral Amino Acid 15% No.580$16,090
Calcium Acetate93$8,941
VascepaIcosapent Ethyl15$3,522
Icosapent Ethyl19$2,609
Clonidine23$2,109
Hydralazine Hcl105$926

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$1,142$152,16152 claims
AstraZenecaLokelma$706$20,38126 claims
Akebia Therapeutics IncAuryxia$938$16,50613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Glendale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →